Soon after the US Food and Drug Administration authorized the Pfizer-BioNTech COVID-19 vaccine, a Centers for Disease Control and Prevention (CDC) advisory committee recommended the vaccine for people aged 16 years and older, stating they found it was safe and effective. Other countries, such as the United Kingdom, have begun vaccine rollout for a large number of at-risk populations and healthcare workers.
The CDC said it will quickly issue guidance to clinicians so they can determine when and when not to give the vaccine and to help them communicate the risks and benefits to patients.
Medscape Reader Polls © 2020
Cite this: How Will You Talk to Patients About a COVID-19 Vaccine? - Medscape - Dec 21, 2020.